Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
35.42
+0.27 (0.77%)
At close: Sep 16, 2025, 4:00 PM EDT
36.30
+0.88 (2.48%)
After-hours: Sep 16, 2025, 7:03 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $20.66 billion as of September 16, 2025. Its market cap has increased by 58.23% in one year.
Market Cap
20.66B
Enterprise Value
28.03B
1-Year Change
58.23%
Ranking
Category
Stock Price
$35.42
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $20.66B, an increase of 31.06%. That is a compound annual growth rate of 5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 15.31B | 35.09% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |